Anaphylaxis Management in the GALAXIA 2022 Update
J Investig Allergol Clin Immunol
.
2023 Dec;33(6):486-487.
doi: 10.18176/jiaci.0962.
Authors
A Prieto-Moreno
1
2
,
Y Puente-Crespo
2
3
,
V Cardona
2
4
,
B de la Hoz
5
6
7
,
M C Dieguez
8
9
,
D González-de-Olano
5
6
,
A Habernau
10
,
C Perales-Chorda
2
11
,
R Muñoz-Cano
2
12
13
14
15
Affiliations
1
Allergy Department, Hospital Universitario Infanta Leonor, Madrid, Spain.
2
Anaphylaxis Committee of the Spanish Society of Allergology and Clinical Immunology (SEAIC).
3
Allergy Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain.
4
Allergy Section, Department of Internal Medicine, Hospital Vall d'Hebron, Barcelona, Spain.
5
Allergy Department, Hospital Universitario Ramón y Cajal, Madrid Spain.
6
Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
7
Universidad de Alcala de Henares, Madrid, Spain.
8
Allergy Department, Madrid, Spain.
9
Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
10
Department of Allergy, Complejo Hospitalario de Mérida, Mérida, Spain.
11
Allergy Department, Hospital de Sagunto, Valencia, Spain.
12
Allergy Department, Hospital Clinic, Barcelona, Spain.
13
Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
14
Universitat de Barcelona, Barcelona, Spain.
15
REI-RICORS, ARADyAL, ISCIII, Madrid, Spain.
PMID:
38095495
DOI:
10.18176/jiaci.0962
No abstract available
Keywords:
Adrenaline; Anaphylaxis; GALAXIA; Guidelines.
MeSH terms
Anaphylaxis* / diagnosis
Anaphylaxis* / drug therapy
Epinephrine / therapeutic use
Humans
Substances
Epinephrine